Pharmacotherapy of Bipolar Depressive Spectrum Disorders

One of the most important needs in treating bipolar disorder is a proper diagnosis, where screening tools such as the Rapid Mood Screener can help. Second-generation antipsychotics have the most data in mixed features, and only lumateperone and quetiapine have proven efficacy data in bipolar II depression. Antidepressants may be safe and effective in certain patients, particularly those with bipolar II. Rapid-acting antidepressants such as ketamine are currently being studied.
Roger McIntyre, MD, FRCPC
Format: Microsoft PowerPoint (.ppt)
File Size: 17.3 MB
Released: December 7, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
Intra-Cellular Therapies
Neurocrine Biosciences
Sage Therapeutics
Sunovion
Supernus Pharmaceuticals, Inc.

Related Content

Dr John M. Kane presents an expert’s guide to tardive dyskinesia, from Clinical Care Options (CCO)

John M. Kane, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credit Released: January 12, 2022 Expired: January 11, 2023

Dr. Greg Mattingly reviews recent advances in treating schizophrenia, from Clinical Care Options (CCO)

Greg Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Social Workers: 1.0 ACE CE Credit Psychologists: 1.0 APA CE Credit Released: January 11, 2022 Expired: January 10, 2023

Sanjay Gupta, MD, on salient research studies of interest relevant to neuroscience, including agitation in dementia, insomnia, antipsychotics in schizophrenia, COVID-19, and provides clinical commentary from Clinical Care Options (CCO)

Sanjay Gupta, MD Released: December 22, 2021

Slides from a presentation that educates clinicians on managing side effects of psychiatric medications.

Joseph F. Goldberg, MD Released: December 8, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings